Search results
Moderna's combo COVID and flu vaccine works better than stand-alone shots on the market, study finds
Morningstar· 5 days agoModerna Inc.'s (MRNA) experimental combination COVID and flu vaccine triggered better immune responses than stand-alone shots currently on the market, according to clinical ...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation...
Morningstar· 2 days agoCAMBRIDGE, MA / ACCESSWIRE / June 13, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that its Phase 3 trial of mRNA-1283, an investigational next-generation COVID-19 vaccine< ...
Gavi launches vaccine programs for Ebola, meningitis, rabies, and hepatitis B
Center for Infectious Disease Research and Policy· 23 hours agoGavi's expanded vaccine portfolio fits its goal of ensuring that lower-income countries have access to key vaccines as soon as possible.
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation...
Digital Journal· 2 days agomRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax ...
FDA Gives Nod to RSV Vaccine for People in Their 50s
US News & World Report· 5 days agoThe U.S. Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their 50s who are at increased ...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
Morningstar· 5 days agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID vaccines in adults 50 years and older ...
FDA gives nod to RSV vaccine for people in their 50s
Medical Xpress· 4 days agoDrugmaker GSK's Arexvy vaccine, as well as vaccines from Pfizer and Moderna, are already approved for use in adults 60 and older, since age brings higher...
Moderna's combo Covid, flu vaccine meets goals in late-stage study - Boston Business Journal
The Business Journals· 5 days agoModerna Inc. is making steady headway on its plan to launch all four products from its respiratory ...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
The Sacramento Bee· 5 days agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID vaccines in adults 50 years and older ...
The Bogus Anti-Trans “Declaration” From a Bogus Medical Organization
The New Republic via Yahoo News· 2 days agoWhat’s particularly frustrating is that nothing new needs to happen for these issues to be thrust...